LL37 (14-21)+Cecropin-P1 (2-9), LC

General Information


DRACP ID  DRACP01917

Peptide Name   LL37 (14-21)+Cecropin-P1 (2-9), LC

Sequence  GKEFKRIVWLSKTAKKL

Sequence Length  17

UniProt ID  P49913  P14661 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma Blastoma Not active up to 128 µM MTT assay 20-24 h 1

Hemolytic Activity  Human erythrocytes: 5%Hemolysis>128 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01917

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C96H162N26O22

Absent amino acids  CDHMNPQY

Common amino acids  K

Mass  231807

Pl  11.37

Basic residues  6

Acidic residues  1

Hydrophobic residues  7

Net charge  5

Boman Index  -2859

Hydrophobicity  -55.29

Aliphatic Index  91.76

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  5500

Absorbance 280nm  343.75

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29282543

Title  Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides

Doi 10.1007/s00726-017-2531-1

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_11171

DRACP is developed by Dr.Zheng's team.